Treatment with proton-pump inhibitors (PPIs) might be associated with neuropsychological side effects. We examined the association between use of PPIs and depressive symptoms in an elderly population. Mood was assessed by the 30-item Geriatric Depression Scale (GDS) in all 344 inhabitants of Tuscania (Italy) aged 75 years and over, without exclusion criteria; depression was defined by a GDS score ≥11. Use of PPIs was associated with a higher GDS score in linear regression analysis (B = 2.43; 95% CI = 0.49-4.38; p = 0.014) after adjusting; also, use of PPIs was associated with increased adjusted probability of depression in logistic regression (OR = 2.38; 95% CI = 1.02-5.58; p = 0.045). Higher PPIs dosages were associated with increased probability of depression (p for trend = 0.014). This association was independent of the diagnosis of peptic disease, as well as the use of antidepressant medications. No association was found between use of H2-blockers or antacids and the GDS score. Calculation of the population attributable risk indicated that 14% of depression cases could be avoided by withdrawal of PPIs. Use of PPIs might represent a frequent cause of depression in older populations; thus, mood should be routinely assessed in elderly patients on PPIs.

Laudisio, A., Nullr, N. I., Gemma, A., Giovannini, S., Lo Monaco, M. R., Vetrano, D. L., Padua, L., Bernabei, R., Zuccala', G., Use of proton-pump inhibitors is associated with depression: a population-based study, <<INTERNATIONAL PSYCHOGERIATRICS>>, 2018; 30 (1): 153-159. [doi:10.1017/S1041610217001715] [http://hdl.handle.net/10807/107053]

Use of proton-pump inhibitors is associated with depression: a population-based study

Laudisio, Alice
Primo
;
Giovannini, Silvia;Lo Monaco, Maria Rita;Vetrano, Davide Liborio;Padua, Luca;Bernabei, Roberto
Penultimo
;
Zuccala', Giuseppe
Ultimo
2018

Abstract

Treatment with proton-pump inhibitors (PPIs) might be associated with neuropsychological side effects. We examined the association between use of PPIs and depressive symptoms in an elderly population. Mood was assessed by the 30-item Geriatric Depression Scale (GDS) in all 344 inhabitants of Tuscania (Italy) aged 75 years and over, without exclusion criteria; depression was defined by a GDS score ≥11. Use of PPIs was associated with a higher GDS score in linear regression analysis (B = 2.43; 95% CI = 0.49-4.38; p = 0.014) after adjusting; also, use of PPIs was associated with increased adjusted probability of depression in logistic regression (OR = 2.38; 95% CI = 1.02-5.58; p = 0.045). Higher PPIs dosages were associated with increased probability of depression (p for trend = 0.014). This association was independent of the diagnosis of peptic disease, as well as the use of antidepressant medications. No association was found between use of H2-blockers or antacids and the GDS score. Calculation of the population attributable risk indicated that 14% of depression cases could be avoided by withdrawal of PPIs. Use of PPIs might represent a frequent cause of depression in older populations; thus, mood should be routinely assessed in elderly patients on PPIs.
Inglese
Laudisio, A., Nullr, N. I., Gemma, A., Giovannini, S., Lo Monaco, M. R., Vetrano, D. L., Padua, L., Bernabei, R., Zuccala', G., Use of proton-pump inhibitors is associated with depression: a population-based study, <<INTERNATIONAL PSYCHOGERIATRICS>>, 2018; 30 (1): 153-159. [doi:10.1017/S1041610217001715] [http://hdl.handle.net/10807/107053]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/107053
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 14
social impact